All In MedTech

Device Trial Radar · NCT03804502

Pilot Study of TearCare System - Long-Term Extension

Last checked: Nov 19, 2026Latest source record: Oct 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

Dec 17, 2018

Primary completion

May 21, 2019

Study completion May 21, 2019

Sponsor

Lead sponsor
Sight Sciences, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 15, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to evaluate the long-term clinical utility, safety, and effectiveness of re-treatment with the TearCare™ System in adult patients with dry eye syndrome who had previously been treated with the TearCare System.

Conditions

  • Dry Eye Syndromes

Interventions

  • TearCareDevice

    The TearCare System warms the eyelids to melt the meibum by applying heat to the external surface of the eyelids for 15 minutes. Following completion of the thermal portion of the procedure, the clinician performs manual expression of each of the eyelids.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Tear Break-Up Time From Extension Study Baseline to Month 1Time frame: 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Central Eye Care

    Arlington Heights, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.